期刊文献+

抑郁模型大鼠脑和心肌组织中一氧化氮一氧化氮合酶水平测定分析 被引量:3

Analysis of the determination of NO and NOS in brain and myocardium of depression model rats
原文传递
导出
摘要 目的检测抑郁模型大鼠脑和心肌组织中一氧化氮(NO)和一氧化氮合酶(NOS)水平,探讨抑郁模型大鼠脑和心肌组织损伤的可能机制。方法采用慢性轻度不可预见性的应激结合孤养制备抑郁模型,采用敞箱实验和糖水消耗实验观察大鼠行为改变,以分光光度法检测大鼠脑和心肌组织中NO和NOS的水平。结果抑郁模型大鼠与正常对照组相比较,脑和心肌组织中NO[脑(8.97±2.22)μmol/g prot,(1.86±1.28)μmol/g prot;心肌(9.67±1.53)μmol/g prot,(2.67±1.08)μmol/g prot]和NOS[脑(9.50±1.89)U/mg prot,(2.3l±0.97)U/mg prot;心肌(11.20±1.47)U/mg prot,(2.53±0.97)U/mg prot]水平均显著增加,差异具有显著性(均P〈0.01)。结论抑郁模型大鼠脑和心肌组织中NO和NOS水平显著增加,并可能参与了抑郁模型大鼠脑和心肌组织的损伤。 Objective To study nitric oxide (NO) and nitric oxide synthase (NOS) in brain and myocardium of depression model rats and to explore the mechanism of brain and myocardium injuryed. Methods The depression model rats were produced by chronic mild unpredictable stress and separation. The behavior of rats were detected by open field test and sucrose consumption test. The contents of NO and NOS were determined with spectrophotometric method. Results Compared with the normal control, the contents of NO [ Brain ( 8.97 ± 2.22 ) μmol/g prot vs ( 1. 86 ± 1. 28 ) μmol/g prot ; Myocardium ( 9. 67 ± 1. 53 ) μmol/g prot vs ( 2. 67 ± 1.08 ) μmol/g prot ] and NOS [ Brain ( 9.50 ± 1.89 ) U/mg prot vs ( 2.31 ± 0.97 ) U/mg prot ; Myocardium ( 11.20 ± 1.47 )U/mg prot vs( 2.53 ± 0.97 )U/mg prot ] in brain and myocardium were significantly increased ( P 〈 0.01 ) of depression model rats. Conclusion The contents of NO and NOS increase significantly in brain and myocardium of depression model rats and it may induce the injury on brain and myocardium of them.
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2009年第7期589-590,共2页 Chinese Journal of Behavioral Medicine and Brain Science
关键词 抑郁 心肌 一氧化氮 一氧化氮合酶 Depression Brain Myocardium Nitric oxide Nitric oxide synthase
  • 相关文献

同被引文献43

  • 1aan her Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. CMAJ ,2009 , 180 : 305-313.
  • 2Gatecki P, Szemraj J, Bie(tkiewicz M, et al. Lipid peroxidation and an- tioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep,2009,61 : 436- 447.
  • 3Sarandol A, Sarandol E, Eker SS, et al. Major depressive disorder is accompanied with oxidative stress:short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol, 2007 ,22:67-73.
  • 4Gawryluk JW, Wang .IF, Andreazza AC, et al. Decreased levels of glu- tathione,the major brain antioxidant,in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsyehopharmaeol, 2011,14:123-130.
  • 5Floen SK, Elklit A. Psychiatric diagnoses, trauma, and suicidiality. Ann Gen Psychiatry,2007,6 : 12.
  • 6Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature,2008,455 : 894-902.
  • 7Rada B, Leto TL. Oxidative innate immune defenses by Nox/Dnox family NADPH nxidases. Contrib Microbiol,2008,15: 164-187.
  • 8Ou XM,Chen K, Shih JC. Glucocorticoid and androgen activation of monoamine oxidase a is regulated differently by PI and Spl. J Biol Chem,2006,281:21512-21525.
  • 9Mattson MP. Glutanmte and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci,2008 ,1144: 97-112.
  • 10Khanna S,Parinandi NL,Kotha SR,et al. Nanomolar vitamin E α-to- cotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection. J Neurochem,2010,112 : 1249-1260.

引证文献3

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部